NRX Pharmaceuticals, Inc. NRXP Q1 2026 earnings
Reported May 15, 2026 · Before market open
Revenue estimate$19.4M
EPS estimate-$0.05
Next report
Aug 17, 2026 (in a month)Revenue estimate$1.7M
EPS estimate-$0.09
Versus estimates
Revenue
Q1 2026$1.1MMiss by $18.4M
Q4 2025$983.0KMiss by $6.5MQ3 2025$242.0KMiss by $7.3MQ1 2025$2.3MQ4 2024$4.0KMiss by $5.0MDiluted EPS
Ask the moment NRX Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did NRX Pharmaceuticals, Inc. report Q1 2026 earnings?
- NRX Pharmaceuticals, Inc. (NRXP) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were NRX Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
- NRX Pharmaceuticals, Inc. reported revenue of $1.1M and diluted EPS of $-0.04 for Q1 2026.
- Did NRX Pharmaceuticals, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $19.4M by $18.4M. EPS beat the consensus estimate of $-0.05 by $0.01.
- How did NRX Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 53.1% from $2.3M a year earlier and diluted EPS grew 88.2% from $-0.34.
- Where can I find NRX Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001437749-26-017397) directly on SEC EDGAR. The filing index links above go to sec.gov.